$VNDA
Vanda Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
$5.03
▼-1.57%-$0.080
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateVanda Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is VNDA down today? It is at $5.03 (-1.57%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VNDA spikes, and full due diligence on VNDA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VNDA 16 times in the last 30 days. Create a free account to track $VNDA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on VNDA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VNDA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystVanda Pharmaceuticals Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mitchell Stephen Ray Director | Acquired (grant/award) | +42K 0.07% of company | added 58% | 113K | n/a | Jun 4, 26 |
Honore Tage Director | Acquired (grant/award) | +42K 0.07% of company | added 45% | 135K | n/a | Jun 4, 26 |
Ward Anne Sempowski Director | Acquired (grant/award) | +42K 0.07% of company | added 35% | 161K | n/a | Jun 4, 26 |
Dugan Richard W Director | Acquired (grant/award) | +42K 0.07% of company | added 23% | 219K | n/a | Jun 4, 26 |
Duncan Charles Cliff Director | Acquired (grant/award) | +42K 0.07% of company | added 73% | 99K | n/a | Jun 4, 26 |
Chrousos Phaedra Director | Acquired (grant/award) | +42K 0.07% of company | added 34% | 165K | n/a | Jun 4, 26 |
Mcguire Daniel Patrick Officer | Acquired (grant/award) | +80K 0.1% of company | added 100% | 110K | n/a | Jun 4, 26 |
Mitchell Stephen Ray Director | Sold (automatic/other) | -26K 0.04% of company | sold 27% | 71K | n/a | May 18, 26 |
Duncan Charles Cliff Director | Acquired (grant/award) | +57K 0.09% of company | n/a | 57K | n/a | Apr 22, 26 |
Birznieks Gunther Officer | Sold (automatic/other) | -42K 0.07% of company | sold 7.9% | 494K | $351K at $8.27 | Mar 2, 26 |
Polymeropoulos Mihael Hristos Officer | Sold (automatic/other) | -156K 0.3% of company | sold 5.5% | 2.70M | $1.3M at $8.17 | Mar 2, 26 |
Wijkstrom Joakim Officer | Sold (automatic/other) | -31K 0.05% of company | sold 8.5% | 333K | $255K at $8.27 | Mar 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on VNDA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VNDA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
VNDA last traded at $5.03, down 1.57% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Vanda Pharmaceuticals Inc. (VNDA) is next expected to report earnings on Wednesday, November 4, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VNDA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VNDA 16 times in the last 30 days.
VNDA (Vanda Pharmaceuticals Inc.) trades on XNAS, with a market cap of about $310M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VNDA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VNDA discussion
Sign in to ask a question or join the discussion.